Sorrento Therapeutics, Inc. Registration Rights Agreements
12 Contracts & Agreements
- Form of Amended and Restated Registration Rights Agreement (Filed With SEC on March 18, 2022)
- Registration Rights Agreement, dated as of February 10, 2020, by and between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 11, 2020)
- Amendment No. 2 to the Registration Rights Agreement, dated as of December 6, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto (Filed With SEC on December 9, 2019)
- Amendment No. 1 to the Registration Rights Agreement, dated as of May 3, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto (Filed With SEC on May 3, 2019)
- Registration Rights Agreement, dated November 7, 2018, by and among Sorrento Therapeutics, Inc. and the parties identified on Schedule A thereto (Filed With SEC on November 9, 2018)
- Registration Rights Agreement, dated June 13, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on June 14, 2018)
- Registration Rights Agreement, dated December 21, 2017, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on December 21, 2017)
- SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2017)
- SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 8, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 19, 2014)
- REGISTRATION RIGHTSAGREEMENT BY AND AMONG SORRENTO THERAPEUTICS, INC. AND THE STOCKHOLDERS OF SHERRINGTON PHARMACEUTICALS,INC. Dated as of October 9, 2013 1 REGISTRATION RIGHTS... (Filed With SEC on October 15, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 23, 2007)